Member Info for Chelsea11

If you ignore the 2 half trading days (22nd & 29th), I make it just 11 full trading days left this year.

Putting to one side an update on the Open Offer, the odds of new news landing before the year are are I guess pretty slim. I was really hoping to see MHRA approval for iSCIB+ by now and was a tad disappointed not to see that in the SCOPE update RNS back end of November. Maybe that will still come.

Best of luck to all those (including myself!), who have applied for extra shares above their allocation.

TF - you been on the weed again? :-0

No need to worry!

https://www.youtube.com/watch?v=qN30JMLOd60

Now also have the invite on ii.

I shall accept!

@ Rigga

Apols I glanced at the email without opening it but in fact is was for my Lloyds Bank / Halifax platform. I have ii platform also but nothing there yet. My mistake.

Just received Corporate Action notification on Int Inv.

Just received Corporate Action notification on Int Inv.

Maybe with news circulating further, the SP will pick up

https://www.uktech.news/news/investment-news/motion-capture-oxford-metrics-revenue-20231205

Yeah I agree Trotsky and I think that encourages investors to just jump from one share to another, due to a loss of patience.

Write up here………..

https://www.voxmarkets.co.uk/articles/oxford-metrics-drivers-to-growth-and-catalysts-for-rerating-cab8960/

I use Interactive Investor and hope to see something under Corporate Actions this week.

CW - you would normally find what you’re looking for under “Corporate Actions” on your Investment Platform.

Are we sure it wasn’t, “that works and we’re in trouble”.

So easy to mis-hear in the general hub-bub ;-)

All baby steps on the way to £8 quid ;-)

I found Berms 21:15 yesterday very interesting:

1) Genmab have advised that they intend to take SC129 into clinical trials.

2) Genmab are interested in another mAb.

So not only is there a live chance that SC129 may in time result in revenue to fuel advancement of other products in the pipeline, industry giant Genmab provide further endorsement of Scancell’s work, by saying another mAb is interesting them.

A Wow for me!

Hope so.

For your sake Violin :-)

Hi Chester. Not sure about “early” 2024 myself.

More Q2 for me but hope you’re right and I’m wrong!

Yeah I think linked to this convo about new news, is what I said yesterday about not yet having MHRA approval for iSCIB+.

When I read that section yesterday, it came across to me as a delay caused by not supplying MHRA, with what they should have known they would ask for before approval could be granted.

That was however just my interpretation and I may be being harsh given I don’t know any MHRA correspondence details, or dates of.

Regardless, it now needs to come quickly so as not to delay further imo.

Not sure the overnight price was set at the correct level going in to this morning. Therefore the drop looks artificially high.

11th December rapidly approaching. We already know from the recent Trading Update……

“Revenue and adjusted operating profit expected to increase by c.13%, with a good mix of organic and acquired growth”

Positive expectations set then, that the Company’s strategy is working well and they are delivering on their promises. It will be interesting to see the detail and of course the future outlook. Not long to wait.